Spinal Tech

Zacks upgraded Caesarea, Israel-based Mazor Robotics to a "buy" rating, according to Dakota Financial News.

The cervical total disc replacement device market is expected to grow at a CAGR of 23.1 percent from 2015 to 2021, according to a Persistent Market Research report.

DFine, a Silicon Valley-based medical device manufacture, commercially launched its Long SpineSTAR Ablation device.

NuVasive stock received an 'outperform' rating from Cowen and Company, according to a MidSouth News & Analysis report.

Zimmer Biomet is one of the three most expensive stocks in the market right now, according to an Economic News Daily report.

Zimmer Biomet reported a quarterly dividend for the fourth quarter of 2015.

Recent clinical studies in Europe examining the AxioMed Freedom total disc replacement technology show favorable results.

NuVasive company shares dropped .39 percent from Dec. 7 through Dec. 11, according to OTC Outlook.

OrthoSensor has raised $3.9 million in a new financing round, according to a Mass Device report.

Houston Methodist Hospital is the first hospital in Houston to implement CT-free robotic orthopedic surgery.